glucura: Typ 2 Diabetes Coach

de.perfood.diabetes

View detailed information for glucura: Typ 2 Diabetes Coach — ratings, download counts, screenshots, pricing and developer details. See integrated SDKs and related technical data.

Total installs
6.5K(6,544)
Rating
unknown
Released
unknown
Last updated
January 1, 1970
Category
Health & Fitness
Developer
Perfood GmbH
Developer details
Name
Perfood GmbH
E-mail
app@perfood.de
Website
unknown
Country
Germany
Address
unknown
Android SDKs
  • No items.
glucura: Typ 2 Diabetes Coach Header - AppWisp.com

Screenshots

glucura: Typ 2 Diabetes Coach Screenshot 1 - AppWisp.com
glucura: Typ 2 Diabetes Coach Screenshot 2 - AppWisp.com
glucura: Typ 2 Diabetes Coach Screenshot 3 - AppWisp.com
glucura: Typ 2 Diabetes Coach Screenshot 4 - AppWisp.com

Description

Personalized Type 2 Diabetes Therapy on Prescription: Your Diabetes Coach in Your Pocket. glucura is the first app specifically tailored to you and your type 2 diabetes, supporting you in effectively lowering your long-term blood sugar (HbA1c).

Developed by physicians in cooperation with nutritionists, glucura has been reviewed by the Federal Institute for Drugs and Medical Devices (BfArM) and approved as a Digital Health Application (DiGA) for people with type 2 diabetes. This means the app can be prescribed by a doctor and billed through health insurance.

Simply have your doctor prescribe glucura, receive your glucura package with everything you need conveniently at home, and start your journey to a blood sugar-stable future with your personal diabetes coach.


At a glance – this is what your pocket-sized diabetes coach offers:

- Monitoring and analysis of your blood sugar – learn how your blood sugar reacts to different foods

- Your diet at a glance – easily keep track of your daily eating habits and nutrient intake

- Personalized program with tips, recipes, and exercises related to nutrition and exercise – tailored to your pace and needs

- Weekly goals with knowledge and motivation – selected according to your preferences

- Comprehensive background information on type 2 diabetes – become an expert yourself and feel confident managing your blood sugar

- Easy integration with fitness trackers and Google Fit – so you don't have to worry about tracking your activities, steps, and weight; Once connected, your data is automatically integrated into glucura and used to document your therapy progress.

- Therapy that adapts to your life – not the other way around.

With glucura, you can achieve:

- Long-term stabilization of your blood sugar
- Slowing the progression of your type 2 diabetes and preventing complications early on
- Sustainable weight loss without the yo-yo effect
- Safe management of your type 2 diabetes

The best part? The app integrates seamlessly into your daily life – diabetes therapy can be simple and straightforward! Your diabetes coach accompanies you on your journey to a healthy lifestyle and helps you develop new habits – without deprivation or cravings, but with more energy and quality of life.

Once the app is activated, glucura is free for people with type 2 diabetes who are not currently on insulin therapy. The prescription can be renewed every three months.


Safety and Regulatory Information

Please note: glucura does not provide a medical diagnosis and is not a substitute for the advice of your doctor. If in doubt, and before making any medical decisions, you should seek professional medical advice.

Instructions for use, information on the suitable target group, contraindications, privacy policy, and further details about glucura can be found at https://glucura.de

Indications for Use
glucura is a program to support the therapy of type 2 diabetes mellitus, according to the diagnostic code ICD-10 E11.-. Its aim is to reduce postprandial blood glucose variability through personalized nutritional recommendations and interaction with activities, medication, and sleep.

Medical Device Notice

This app is a Class I medical device according to Rule 11 of Annex VIII, Chapter III, Section 6.3 of Regulation 2017/745/EU (MDR).